Publication | Open Access
3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
71
Citations
43
References
2018
Year
Taken together, these results suggest that AKBA (molecular weight, 512.7 Da) might be a promising chemotherapy drug in the treatment of GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1